| Name | Title | Contact Details |
|---|---|---|
Brian Mason |
Head of Research and Development | Profile |
Jingzi Sherman |
Vice President of Research and Development and Clinical | Profile |
Safari Circuits is a Otsego, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
sbifinechemicals is a EDMONTON, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
B T Medical Co is a Bridgeport, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.